SAN CARLOS, Calif., Sept 13, 2007 /PRNewswire-FirstCall via COMTEX News Network/ --
Nektar Therapeutics (Nasdaq: NKTR) announced that Howard W. Robin, president and CEO, will deliver the corporate presentation at the upcoming 2007 UBS Global Life Sciences Conference in New York at the Grand Hyatt Hotel on Wednesday, September 26, 2007, at 11:00 a.m. ET.
The presentation and Q&A session will be accessible via a live audio-only Webcast through a link posted on the Investor Relations, Events Calendar section of the Nektar website: http://www.nektar.com. This Webcast will be available for replay until October 10, 2007.
Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled nine approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.
SOURCE Nektar Therapeutics
http://www.nektar.com
Copyright (C) 2007 PR Newswire. All rights reserved
News Provided by COMTEX